McKinsey agrees to $550 million opioid-claim settlement

By Jef Feeley
Published 4 Min Read

Bloomberg News

McKinsey has agreed to pay $573 million to settle claims by U.S. states that the consulting company helped fuel the opioid epidemic by providing marketing advice to drugmakers including Purdue Pharma and Johnson & Johnson.

New York-based McKinsey will also produce tens of thousands of its internal documents detailing its work for Purdue Pharma and other opioid companies for public disclosure online, according to a statement by North Carolina Attorney General Josh Stein, who helped lead negotiations on behalf of dozens of U.S. states.

Jef Feeley
From Bloomberg News

For reprint and licensing requests for this article, click here.


More From Employee Benefit News

Sign Up Form

Login Modal Form